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Heterologous  anti-lymphocyte serum  has  been  reported  to  be  the  most 
potent immunosuppressive agent yet described (1). It has been shown that this 
antiserum not only prolongs the survival of skin or renal allografts in mice (2), 
rats (3),  and dogs (4),  but that it is able to suppress an allograft rejection al- 
ready in progress (5).  Furthermore, this remarkable immunosuppressive effect 
can be achieved without causing apparent toxicity in the recipients (1).  These 
features have  stimulated the  use  of heterologous antilymphocyte serum  in 
human clinical trials (6). 
Previous reports have been limited to studying the action of heterologons 
anti-lymphocyte serum upon the lymphoid system. Little investigative work 
has been done on the effect of the antiserum on the closely related hemopoietic 
system. This is quite surprising in view of the demonstrated side effects ac- 
companying prolonged  antiserum treatment.  Monaco  and his  associates  (2) 
reported the occurrence of a  severe wasting disease leading to death in mice re- 
ceiving chronic injections with rabbit anti-mouse lymphocyte serum. Iwasaki 
and coworkers (7)  described the development of anemia in dogs treated with 
horse  anti-dog lymphocyte serum  despite  the  proved  absence  of hemagglu- 
tinins. 
The present study was undertaken to determine the effects of heterologous 
anti-lymphocyte serum upon hemopoietic stem cells which are essential for the 
maintenance of normal marrow function. The morphologic identity of the hemo- 
poietic stem cell has not been established. For this reason,  assay procedures 
for such cells  must be based on their functional characteristics.  The  spleen 
colony assay of Till and McCullock (8)  provides a  unique method for quan- 
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titating stem cells. This technique depends upon the capacity of multipotential 
cells contained in normal mouse hemopoietic tissues to  give  rise  to  clonal 
progeny which  form macroscopic  nodules in the  spleens of  irradiated mice. 
Each of these colonies have been demonstrated to be formed by a  single pre- 
cursor cell (9).  This parent cell, designated as  a  colony-forming unit (CFU), 
possesses the properties characteristic of a  stem cell. They are capable of self- 
renewal (10),  exhibit extensive clonal proliferation, and their progeny differ- 
entiate into three cell lines: erythrocytes, myelocytes, and megakaryocytes (8, 
12). 
In this report, the effects of rabbit anti-mouse lymphocyte serum (RAMLS) 
upon mouse bone marrow were  investigated using conventional morphologic 
studies in combination with the spleen colony assay. Particular emphasis was 
placed on determining the effects of such treatment on hemopoietic stem cells 
as represented by the CFU cell population. 
Materials and Methods 
Animals.--New Zealand white rabbits,  purchased from commercial suppliers, were used 
to produce the antiserum. Mice of the A/Jax and CBA/Jax strains, obtained from the Jack- 
son Laboratories (Bar Harbor, Maine), were used in all grafting procedures and for lympho- 
cyte donors. Inbred mice of the CsI=[/I-Ie  strain, maintained in this laboratory, were utilized 
as both donors and recipients for the spleen colony assay. 
Preparation of An~i-Lymphocyle Serum.--Rabbit anti-mouse  lymphocyte serum (RAMLS) 
was prepared  according to  the method of Gray and associates (12) by immunizing New 
Zealand white rabbits with lymphocytes obtained from A/Jax mice. Complement in the pooled 
serum was inactivated by heating to 56°C for 30 rain. The decomplemented serum was steri- 
lized by passage through a 0.45/z membrane filter, frozen, and stored at --20°C until used. 
Anti-Lymphocyte Serum Assay Procedures.- 
Skin grafting: All RAMLS was assayed for its ability to prolong the survival of CBA/Jax 
skin homografts on A/Jax mice using standard full thickness skin grafting techniques. The 
recipient mice were treated with 0.5 ml of antiserum on day 0 and +2. Grafts on the treated 
mice enjoyed a 20-30 day survival whereas the untreated recipients' grafts were rejected in 
less than 12 days. 
Erythro-agglutinin titer: Hemagglutinin titers were determined using a modification of the 
microtiter technique of Sever (13). A 1% red cell suspension was prepared by adding washed 
peripheral erythrocytes from C3H mice to phosphate-buffered saline (pH 7.2) containing 1% 
isologous serum. Serial dilutions of the serum were added to equal volumes of the above red 
cell  suspension and incubated at room temperature for 2 hr prior to reading. The end point 
of the titration was the last dilution showing complete agglutination. 
Leuko-aggl~inin  titer: Leuko-agglutinin titers  were determined  using a  modification of 
the Amos and Peacocke (14) method. A cell suspension was prepared from lymph nodes ob- 
tained from A/Jax mice as described by BiUingham (15). The cells were washed three times 
in Hanks' balanced salt solution and diluted to a final concentration of 14 X  106/ml. Equal 
volumes of cells and serial dilutions of serum were mixed and incubated at room temperature 
for two hours. 1 drop of each cell suspension was transferred to a glass slide. Agglutination 
was scored microscopically on these wet preparations. The end point was the last dilution 
showing agglutination. 
Absorption oJ Erythro- and Leuko-Agglubinin from the Crude Anti-Lymphocyte  Serum.-- 
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with washed mouse erythrocytes at 4°C utilizing a ratio of 2 volumes of serum to 1 volume of 
cells.  The absorbed serum was decanted from the cells and sterilized by passage through a 
0.45/z  membrane filter. The leuko-agglutinin was deleted from the crude serum by a similar 
absorption  with  suspensions  of  mouse  lymph  node  cells.  Leuko-agglutinin  and  erythro- 
agglufinin titers were established on the absorbed sera prior to use by the described assay 
procedures. 
Spleen Colony Assay.--The spleen colony assay of Till and MeCullock  (8)  was utilized 
to determine the effect of RAMLS on the CFU or hemopoietic stem cell.  Within 4 hr after 
lethal irradiation, C3H/He mice were inoculated with the appropriate isologous bone marrow 
cell suspensions by tall vein injection. 9 days later colony counts were made by dissecting the 
spleens from sacrificed irradiated hosts and counting in the blind the number of macroscopic 
nodules.  Scoring was done with the aid of a  dissecting microscope on both fixed and fresh 
specimens. 
X-Ray  Irradiatdon Procedures.--Prior to  bone  marrow  transfusion,  the  recipient  mice 
were irradiated in individual compartments of a  square lucite box placed 50 cm from the 
target of a 200 kvp Keleket X-ray generator, operated at 15 ma tube current with a 0.5  mm 
A1 filter. The absorbed dose received by these animals was 800 rads given over a  period of 
6 rain and 8 sec. No autochthonous spleen colonies were observed in control animals sacrificed 
at 9 days postirradiation. 
Preparc~iam of Bone Marrow Cell Suspens/ons.--Standard bone marrow cell suspensions 
were prepared from the femurs of donor CsH/He mice.  Nucleated cell counts were  made 
using trypan blue exclusion as an index of viability. The final cell suspension was adjusted by 
dilution with Hanks' solution to the concentration of 2.5 X  lif  t, 3.5 X  lif  t, or 1 X  l0  s cells/ml, 
depending upon the requirements of the experiment. Bone marrow cell suspensions used for 
the control and experimental groups in each in vitro study were obtained from the same 
donor. 
Incubation Procedures.--All in vitro incubations were made by suspending 1 X  106 marrow 
cells in the various stated dilutions of RAMLS or normal rabbit serum (NRS). These mixtures 
were then incubated for 30 rain at 37°C in the presence of guinea pig complement. Unless 
otherwise stated, the cell suspension for injection was prepared by diluting the incubated 
mixture with Hanks' solution to a final concentration of 25,000 cells/mi. A control incubation 
of cells with guinea pig complement and Hanks' solution only was included in each study. 
In one experiment, to be identified later, complement was purposely excluded from the in- 
cubation procedure. 
ttistology.--All  tissues for histological examination were fixed in 10% formalin, embedded 
in paraffm, sectioned at 5/z, and representative sections stained with hematoxylin and eosin. 
Smears of bone marrow cell suspensions and marrow prints were prepared by standard meth- 
ods, air dried, and stained with Wright's stain. All differential counts were based on 1000 cells. 
RESULTS 
In  Vitro Effect of RAMLS on the CFU CelL--The  injection of 25,000 bone 
marrow cells after in vitro incubation with Hanks' solution produced a mean 
number of 7.6 colonies per spleen in the lethally irradiated recipients. Inocula- 
tion of the same number of cells exposed to NRS resulted in a mean of 7.8 colo- 
nies.  However,  animals  receiving bone marrow cells previously  incubated  in 
vitro with RAMLS  had only 0.8  colonies per spleen  (Table I).  Histological 
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originating from marrow suspensions variously treated with RAMLS, NRS, or 
Hanks' solution. 
Characterization of the Bone Marrow Cell Population Surviving Treatment with 
RAMLS.--In the previous study cell counts were made prior to incubation, 
and the final number of cells inoculated was achieved by dilution based on the 
initial count.  Subsequent observations indicated that  approximately 50%  of 
the marrow cells were lysed during the in vitro incubation with RAMLS. In 
the present experiment an effort was made to establish whether the decrease in 
CFU cells was due to a random lysis of all marrow cell types or a selective ac- 
tion on the stem cell population. Thus, the answers to the following questions 
were sought: (a) what portion of the original one million bone marrow cells sur- 
vived incubation with RAMLS; (b) what was their viability based  on trypan 
blue exclusion; (c) what was the CFU content of exactly 25,000 of these ceils; 
(d) what morphological cell types made up this population? 
TABLE  I 
In Vitro Effect of RAMLS on CFU Cells 
No. of isogeneic 
bone marrow 
cells 
1 X  106 
1 X  100 
1 X  10  e 
Incubation 
Serum 
Hanks' 
NRS 
RAMLS 
Dilution 
m 
1:50 
1:50 
No. of cells 
injected per 
host based 
on dilution 
25,000 
25,000 
25,000 
No. of spleen 
colonies  per host 
8, 7, 7, 6, 10, 8 
8, 7, 10, 7, 8, 7 
1, O, O, O, 1, O, O, 7, 
O, 0 
~/[ ean  no. 
of  colonies 
7.6 
7.8 
0.8 
One million bone marrow cells were incubated in either RAMLS, NRS, or 
Hanks' solution for 30 mill. The number of viable cells were counted after incu- 
bation.  As can be seen from Table II  approximately one-half of the original 
one million bone marrow cells survived exposure to RAMLS. Those cells lost 
during  incubation were  apparently lysed,  since there  were few  trypan  blue 
stained cells present in the counting chamber and virtually no cell agglutination 
occurred. Cells incubated in NRS and Hanks' solutions remained viable and no 
lysis was observed. 
The cells  surviving separate  incubations  with  RA_MLS,  NRS,  or  Hanks' 
solution were adjusted to a concentration so that exactly 25,000 of these viable 
cells were injected into each irradiated recipient. The results in Table II show 
that  those  animals  receiving cells  incubated  with  NRS  or  Hanks'  solution 
formed a mean of 8.6 colonies per spleen, while irradiated mice inoculated with 
cells incubated with RAMLS possessed a mean of 2.2  colonies per spleen. This 
could be interpreted as a selective destruction of CFU cells in the marrow popu- T.  R.  DEMEESTER,  N.  D.  ANDERSON,  AND  C.  Y.  SHAFFER  735 
lation incubated with RAMLS, since all irradiated recipients received an iden- 
tical number of viable cells. 
Table III shows the cell differential counts done on a bone marrow cell popu- 
lation incubated with either RAMLS, NRS, or Hanks' solution. As can be seen, 
incubation with RAMLS, compared to NRS or Hanks' solution, caused a  73 % 
decrease in the number of undifferentiated blast cells and a  94 and 98 %  de- 
crease in lymphocytes and nucleated erythrocytes respectively. 
TABLE  II 
CFU Cell Content of Marrow Populations  Survivin 
No. of 
isogeneic 
bone marrow 
cells 
1X  10  e 
1X  10  e 
1 X  10  0 
Incubation 
Serum 
Hanks' 
NRS 
Dilution 
m 
I:100 
1:100 
No. of 
viable cells 
after 
incubation 
1 X  l0  s 
1 X  10  s 
570,000  RAMLS 
No. of 
cells 
injected 
per host 
based on 
actual 
count 
25,000 
25,000 
25,000 
In Vitro Eacposure to RAMLS 
No. of spleen colonies 
pet host 
9, 9, 9, 10, 9, 8, 6 
7, 12, 12, 7, 7, 7, 10, 8, 
8, 8, 9, 12, 6 
0, 1, 1, 7, 0, 9, 0, 0 
Mean No. 
of colonies 
8.6 
8.6 
2.2 
TABLE  HI 
Differential  Cell  Counts*  of Marrow Populations Suroivin  In  Vitro Ex bosure to RAMLS 
Undiffetenti-  Nucleated  Serum incubation  a~ed blast cells  Myelocytes  Lymphocytes  etythrocytes 
Hanks' solution  50  807  90  53 
NRS  52  751  101  96 
RAMLS  14  980  4  2 
* Based on 1000 cells counted. 
In  Vitro Effect of Erythrocyte-Absorbed RAMLS on the CFU CelL--Studies 
were carried out to establish whether the suppression of CFU cells by RAMLS 
could be related to its erythro-agglutinating activity. Bone marrow cell sus- 
pensions  were  incubated  separately with  crude RAMLS  (erythro-agglutinin 
titer  1:1024),  erythrocyte absorbed  RAMLS  (erythro-agglutinin tater  1:4), 
NRS, and Hanks' solution; and their resultant CFU cell content assayed. Table 
IV shows  that prior incubation of marrow  ceils in  crude or  erythrocyte-ab- 
sorbed serum resulted in  a  similar number of 0.7  and 0.9 mean colonies per 
spleen respectively. Ceils exposed to NRS gave a mean  of 7.8 colonies which 
compared favorably with the mean of 8.0 colonies per spleen from cells incu- 736  ANTI-LYM2PHOCYTE SF.RUM  AND  HEMOPOIETIC  STEM  CELLS 
bated in Hanks' solution. Thus, the effect of RAMLS of the CFU cell appeared 
independent of the erythro-agglutinin titer of the antiserum. 
In  Vitro  Effect  of Leukocyte-Absorbed  RAMLS  on  the  CFU  Cell.--Experi- 
meats were done to determine whether the leuko-agglutinin activity of RAMLS 
TABLE IV 
In Vitro Effect of Erythrocyte-Absorbed RAMLS on CFU Cells 
Incubation 
No. of 
isogeneic 
bone marrow 
cells 
1 X  10  6 
1  X  10  6 
1 X  106 
1 X  10  6 
Serum 
Hanks' 
NRS 
Crude RAMLS 
Absorbed 
RAMLS 
Dilution 
1:50 
1:50 
1:50 
Erythro-  No. of cells 
a~glutinin  injected per 
tater of  host based 
undiluted  on dilution 
scrul~ 
0 
1:1024 
1:4 
25,000 
25,000 
25,000 
25,000 
No. of spleen 
colonies per host 
7, 12, 9, 6, 9, 7, 7, 8, 8, 
7,8 
8, 6, 13, 8, 6, 8, 7, 6 
1, 0, 4, I, 0, 1, 0, 0, 0, 
4, 1, 0, 0, 1, 0, 1, 0, 0, 
1,2 
Mean 
No. of 
colonies 
8.0 
7.8 
0  0.7 
0.9 
TABLE V 
In Vitro Effect of Leukocyte-Absorbed RAMLS on CFU Cells 
Incubation 
No. of 
isogenclc 
bone marrow  Serum 
cells 
1 X  106  Hanks' 
1 X  10  s  NRS 
1 X  10  e  Crude 
RAMLS 
1 X  106  Absorbed 
RAMLS 
Dilution 
1:800 
1:800 
1:800 
Leuko- 
agglutinin 
titer of  th 
undiluted 
serunx 
0 
1:400 
<1:5 
No. of cells 
injected per 
host based 
on dilution 
25,000 
25,000 
25,000 
25,000 
No. of spleen 
colonies per host 
9, 9, 9, 10, 9, 8, 6 
7, 7, 10, 8, 8, 8, 9 
0, 2, 1, 1, 0, 0, 2, 1 
1, 1, 1, 1, 3, 2, 3, 2, 1, 
5, 3 
Mean 
No. of 
cnionie! 
8.6 
8.1 
0.9 
2.1 
was  responsible  for  its  suppressive  effect  on  the  CFU  cell.  Crude  RAMLS 
(leuko-agglutinin  titer  1:400),  leukocyte-absorbed  RAMLS  (leuko-agglutinin 
fiter  <  1:5),  NRS,  and  Hanks'  solution  were  incubated  individually  with 
marrow  cells  and  their  effect  on  the  CFU  cells  compared.  Since  the  leuko- 
agglutinin assay was relatively insensitive, all incubations were done in a  1:800 
dilution of serum so as to further dilute any leuko-agglutinin activity remaining T.  R.  DEMEESTER, N.  D.  ANDERSON~ AND C.  ~.  SHAFYER  737 
in  the  absorbed antiserum.  Cells incubated  in  crude RAMLS, leukocyte  ab- 
sorbed RAMLS, NRS,  or Hanks' solution resulted in a mean of 0.9,  2.1,  8.1, 
and 8.6 colonies per spleen respectively (Table V). Comparison of these results 
suggested that the action of RAMLS on the CFU cell was not correlated with 
leuko-agglutinating activity of the antiserum. 
Comparison  of the In Vitro Cytotoxidty of RAMLS with its Suppressive  Effect 
upon CFU Cells.--This study was undertaken to compare the cytotoxic effect 
of various dilutions of RAMLS on bone marrow cells and peripheral lympho- 
100"  e~"¢~/ 
BONE  MARROW  ,A  t  / 
CELLS  l  / 
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X  CELLS  I  / 
,~  e--e  CFU  CELLS  /  / 
z  60"  .,,¢,  l  ./  /  / 
ao.  /  /. 
•  e/ 
1'50  1,100  1,200  1=400  1,800  1,1600 
DILUTIONS  OF RAMLS 
TExT-FIo. 1.  Comparison of the  cytotoxic effect on bone marrow cells and peripheral 
lymph node ceils  with the suppression  of CFU ceils  produced by various dilutions of RAMLS. 
Survival index is the per cent of cells surviving incubation in antiserum compared to the 
controls exposed to NRS at the same dilutions. 
cytes to the suppressive action of the same dilutions of antiserum on the CFU 
cell  content  of  these bone marrow preparations.  Suspensions  on one  million 
bone marrow cells or lymphocytes were incubated separately at various dilutions 
of RAMLS or NRS. The cytotoxic effect on the incubated cells was determined 
by cell counts using trypan blue exclusion. The suppressive action on the CFU 
cells present in the same bone marrow suspensions was assayed using the spleen 
colony technique. The results are displayed graphically in Text-fig. 1 by plotting 
the survival index of CFU cells, marrow cells, and the peripheral lymphocytes 
against the various dilutions of RAMLS. The survival index is the percentage 
of cells surviving incubation with RAMLS compared to controls incubated in 
NRS at the same serum dilutions. Note that only 20 % of the CFU cells in the 
marrow population survived incubation with 1:1600 dilution of RAM-LS com- 738  ANTI-LYMPHOCYTE  SERUM  AND  HEMOPOIETIC  STEM  CELLS 
pared to a  100% survival of marrow ceils and  peripheral  lymphocytes incu- 
bated at the same concentration. This indicated that a significant suppressive 
effect of RAMLS on the CFU cells occurred in vitro at a dilution which showed 
no detectable cytotoxic effects on the marrow  cell population or peripheral 
lymphocytes, and  that  stem  cell proliferation was  prevented by very small 
concentrations of the antiserum. 
In  Vitro Effect of RAMLS  on  the  CFU  Cell  When Incubated  without  Com- 
plement.--In  all previous studies,  incubations  were done in  the  presence of 
guinea pig complement and, as stated, a significant degree of cell lysis occurred. 
Similar studies, using mouse serum as the source of complement, showed that 
no cytolysis or demonstrable cell injury occurred when bone marrow ceils were 
incubated  with  RAMLS.  This  observation  raised  the  question whether  the 
detrimental effect of RAMLS  on CFU  ceils was  dependent upon a  cytotoxic 
action produced only in the presence of guinea pig complement. Standard bone 
TABLE VI 
The Effect of RAMLS on CFU Cells When Irmubated without Complement Added In  Vitro 
Incubation (without complement) 
No.  of  isogenelc 
bone msrrow  Serum  Dilution 
ceils 
1  X  10  6 
1X  10  6 
1X  10  6 
Hanks' 
NRS  1:2 
RAMLS  1: 2 
No. of cells 
injected per 
host  based 
on dilution 
25,000 
25,000 
25,000 
No. of spleen 
colonies  per host 
5, 5, 5, 6, 1 
6, 6, 5, 5, 4 
0, 0, 0, 1, 2, 0, 0 
Mean 
No. of 
colonies 
4.4 
5.2 
0.4 
marrow  suspensions  were  incubated  with  either  RAMLS,  NRS,  or  Hanks' 
solution in the absence of complement. Mter incubation, cell counts demon- 
strated that virtually all cells survived without injury as manifested by trypan 
blue exclusion. These cells were then injected into irradiated isogeneic hosts to 
determine the number of CFU cells capable of colony formation. The results 
are  shown  in  Table VI  and  indicated  that  the suppression  of CFU  cells by 
RAMLS was not dependent upon in vitro exposure to guinea pig complement. 
In  Vivo Effect of Erytkrocyte-Absorbed  RAMLS  on CFU Cells  Transplanted 
into  a  Lethally Irradiated  Recipient.--The  previous experiments have demon- 
strated  that RAMLS,  when incubated  with a  bone  marrow  cell  suspension 
in vitro, reduced the number of CFU cells present in the treated population. 
Studies were then initiated to determine whether a similar effect could be dem- 
onstrated  in  vivo.  Suspensions  containing 35,000  normal bone marrow  ceils 
were injected intravenously into lethally irradiated isogeneic mice. Immediately 
afterwards, these animals received an intravenous injection of 0.1 ml of RAMLS 
or Hanks' solution. For control purposes a second separate suspension contain- T. R. DEMEESTER,  N. D. ANDERSON,  AND  C. ~F. SHAI~FER  739 
ing 25,000 isogeneic bone marrow cells per inoculum was similarly injected and 
chased with 0.1 ml of NRS or Hanks' solution. Table VII shows the results of 
these experiments. A mean of 4.8 colonies were formed when the marrow inocu- 
lure was followed by a RAM-LS injection compared to a mean of 9.9 resulting 
from similar treatment with Hanks' solution. The intravenous injection of NRS 
or Hanks' solution after inoculation of the marrow suspension yielded the same 
mean number of spleen colonies. Thus, the administration of RAMLS in vivo 
caused a 50 % reduction in the number of spleen colonies formed by the trans- 
planted marrow cells.  It was observed that this activity of RAMLS was de- 
pendent on the time interval between the injection of the marrow cell suspen- 
sion and the antiserum. The inoculation of 0.1-0.2 ml of RAMLS into irradiated 
hosts 1 or more hr prior to infusion of the marrow cells failed to reduce the 
TABLE  VII 
In Vivo Effect of RAMLS on CFU Cells Transplanted into Irradiated Mice 
No. of 
isogeneic 
bone marrow 
cells 
35,000 
35,000 
25,000 
25,000 
Treatment of  Irradlated Host 
Serum 
Hanks' 
RAMLS 
erythrocyte- 
absorbed 
Hanks' 
NRS 
Dose injected* 
0.1 cc i.v. 
0.1 cc i.v. 
O. 1 cc i.v. 
O. 1 cc i.v. 
No. of spleen colonies 
per host 
10, 10, 9, 8, 9, 13, 10 
5, 2, 4, 7, 3, 6, 6, 3, 
4, 8 
7, 4, 9, 9, 7, 5, 9, 9 
5, 8, 6, 9, 7, 6, 8, 7 
8, 9, 10, 8 
Meall 
No. of 
colonies 
9.9 
4.8 
7.3 
7.5 
SD 
1.2 
1.8 
u 
* All injections were made immediately  after marrow infusion. 
number of spleen colonies formed, suggesting that the heterologous antibodies 
were rapidly removed from the recipient's peripheral blood. 
The In  Vivo Effect of Erytkrocyte-Absorbed  RAMLS  on Normal Bone Mar- 
row.--Having established that RAMLS could act in the irradiated animal to 
reduce the number of spleen colonies produced by transplanted marrow cells, 
studies were undertaken to determine the possible effect of this antiserum upon 
hemopoietic stem cells situated in the marrow tissues of normal mice. Three 
groups of eight mice received a  single 1 ml intravenous injection of RAMLS, 
NRS,  or Hanks'  solution respectively. 24 hr later the mice were sacrificed. 
Pooled bone marrow cell suspensions were made from the animals in each group 
and their CFU cell content assayed. Mice acutely treated with RAM:LS had a 
mean of S.1 colonies per spleen. Animals similarly treated with NRS or Hanks' 
solution showed means of 10.3  and 9.7  colonies per spleen (Table VIII).  No 740  ANTI-LYMPHOCYTE SERUM  AND  HEMOPOIETIC  STE~  CELLS 
significant difference was observed in the total cell content of femoral marrows 
obtained from animals treated with RAMLS, NRS, or Hanks' solution. Thus, 
a  single injection with RAM-LS  caused, within 24 hr, a  50%  decrease in the 
number of CFU cells contained in the bone marrow of treated mice. 
An  additional  effort was made  to ascertain  the effect of chronic RAMLS 
treatment on the bone marrow of individual mice. Three groups of mice were 
treated daily with 0.25 cc subcutaneous injection of either RAMLS, NRS, or 
Hanks' solution. Members of each group were sacrificed after 1 and 3 wk of 
treatment.  A  cell suspension was  prepared from  the  bone  marrow  of each 
animal and analyzed for the CFU cell content. Table IX shows that after 1 wk, 
animals  treated with RAMLS  had a  group mean of 3.5  colonies per spleen. 
Injection of the same number of bone marrow cells from mice similarly treated 
TABLE VIII 
CFU Cell Content of Mouse Bone Marrow 24 Hr after Injection of RAMLS In  Vivo 
Treatment of marrow donors 
No. of  Dose per 
mice  Serum 
treated  mouse 
Hanks' 
NRS 
RAMLS 
erythrocyte- 
absorbed 
1 cc i.v. 
1 cc i.v. 
1 cc i.v. 
No. of 
cells 
injected 
per host 
from 
pooled 
marrow o 
treated 
donors 
25,000 
25,000 
25,000 
No. of spleen colonies 
per host 
9, 10, 10, 7, 15, 7, 10 
12, 10, 12, 16, 10, 9, 6, 17 
9, 8, 0, 6, 5, 2, 5, 5, 6 
lean 
o. ot 
[oni~ 
9.7 
0.3 
5.1 
SD 
2.5 
3.6 
2.6 
with NRS and Hanks' solution formed a group mean of 8.0 and 7.9 spleen col- 
onies. A similar suppression of CFU cell content was found in the marrows of 
animals treated with RAMLS for 3 wk. 
Microscopic studies of the marrow imprints from mice treated with RAMLS 
for 3 wk showed marked depletion of lymphocytes, erythroid precursors, and a 
decrease in the number of undifferentiated blast ceils. The majority of the mar- 
row population was  composed of myelocytes in various stages of maturation 
(Fig.  1 a  and 1 b). Table X  shows differential cell counts made on individual 
marrow suspensions prepared from mice treated for 3 wk with RAM-LS. These 
marrow specimens showed a  50 %  decrease in undifferentiated blast ceils and 
greater than an 85 %  reduction in the number of lymphocytes and nucleated 
erythrocytes when compared to marrow specimens from control animals. These 
in vivo findings were similar to the results observed in marrow suspensions in- 
cubated in vitro  with antiserum  (Table III).  Thus,  chronic treatment  with T.  R.  D~MF,  ESTER~  N.  D.  AND:ERSON~  AND  C,  Y.  SHA:F:FER  741 
TABLE IX 
CFU Cell Content  of Mouse Bone Marrow after  Prolonged In  Vivo  Treatment  with RAMLS 
Dnra- [ 
tion of 
treat- 
ment I 
ii 
Donor treatment 
Serum 
Hanks' 
NRS 
RAMLS 
erythroeyte- 
absorbed 
1 
1 
Hanks'  ! 
I 
i NRs  I 
I 
i  i 
I 
RAMLS 
erythr~yte- 
absorbed 
i 
l 
i 
I 
i 
Dose per day 
0.25 cc s.c. 
0.25 cc s.c. 
0.25  cc s.c. 
O. 25 cc s.c. 
O. 25 cc s.c. 
0.25 cc s.c. 
No. of  Mean  Mean 
cells  Donor  No. of spleen  No. of  No. of 
injected  No.  colonies per host  colonies  colonies 
per host  d~eonrr  per grout 
25,000  1  7, 12, 9, 6, 9,  8.0 
7, 7, 8, 8, 
7, 8 
2  8,7,7,6,10,8  7.6 
1  6, 5, 7, 10, 9,  7.6 
5, 8, 8, 7, 
9, 9, 8 
2  11, 7, 11, 8, 9  9.2 
1  2, 1, 3, 1, 2,  1.6 
1,1 
2  4, 1, 6, 4, 5,  4.7 
9, 4, 7, 3, 
6, 4, 4 
25,000 
25,000 
25,000 
25,000 
25,000 
1  9, 9, 9, 10, 9,  8.6 
8,6 
2  4, 8, 6, 8, 4,  6.4 
6, 4, 8, 3, 
8, 9, 9 
1  9, 10, ,5, 14,  9.5 
8, 6, 9, 9, 
6, 12, 17 
2  9, 10, 11, 9,  8.5 
7, 7, 6, 9, 
8, 8, 10, 10 
1, 1, 2, 3, 2,  2.3 
2, 4, 1, 5 
5, 8, 1, 5, 1,  3.0 
2, 1, 0, 3, 
0,5 
9, 5, 4, 2, 5,  4.5 
2, 4 
4, 5, 2, 2, 4,  2.9 
4, 1, 2 
3, 7, 6, 3, 2,  3.0 
1, 2, 1, 2 
SD 
7.9  1.4 
8.0 
3.5 
7.2 
9.0 
3.0 
1.7 
2.2 
2.1 
2.6 
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RAMLS  altered  the  cellular composition and decreased the number of func- 
tional stem cells in the bone marrow. 
The Effect of Erythrocyte-Absorbed RAMLS Treatment on the Survival of Mice 
Exposed  to a Sublethal Dose of X-Ray Irradiation.--The  previous study illus- 
trated  that the  treatment of normal mice with RAMLS reduced the number 
of CFU cells in their bone marrow. The following experiment was carried out 
to determine if this process could summate with the bone marrow insult pro- 
duced  by sublethal  irradiation  and  cause increased  mortality in  the  treated 
animals.  Three groups of mice were irradiated with 600 R  and  then injected 
subcutaneously with 0.25 cc. of either RAMLS, NRS, or Hanks' solution daily. 
By 30 days after irradiation,  100 %  (15/15) of mice receiving RAMLS in com- 
bination with irradiation had died with 80 %  of the deaths occurring between 
TABLE  X 
Differential Cell Counts* of Marrow Populations from  Mice  Treated Daily with RAMLS, 
NRS, or Hanks' Solution for 3 Wk 
Undifferentiated  Nucleated 
Serum treatment  blast cells  Mye]ocytes  Lymphocytes  erythrocytes 
Hanks' solution 
Donor No. 1 
Donor No. 2 
NRS 
Donor No. 1 
Donor No. 2 
RAMLS erythocyte-absorbed 
Donor No. 1 
Donor No. 2 
Donor No. 3 
48 
44 
34 
23 
17 
11 
12 
704 
654 
708 
683 
976 
966 
970 
112 
55 
108 
85 
7 
18 
14 
136 
236 
150 
209 
* Based on 1000 cells counted. 
the 8th and 19th postirradiation day. No mortality was observed in a compara- 
ble panel of normal mice treated with RAMLS only, or irradiated  mice treated 
with  NRS  or  Hanks'  solution  respectively.  These  findings  indicated  that 
RAMLS  given  concomitantly with sublethal  irradiation  caused an increased 
mortality in the recipients. 
DISCUSSION 
These experiments have demonstrated that RAMLS has a  deleterious effect 
on mouse bone marrow cells in vitro and in vivo. Antiserum treatment caused 
a  marked loss of functional  hemopoietic stem cells from the  treated marrow 
population, and this was accompanied by a depletion of marrow lymphocytes, 
erythroid precursors, and undifferentiated blast cells.  The concept that a  hu- 
moral antibody can destroy bone marrow is not new. There have been several 
experiments indicating that heterologous antiserum evoked against bone mar- 
row cells or peripheral lenkocytes can disrupt hemopoiesis and cause marrow T.  R.  DvM'~.EST~ER, lq.  D.  ANDERSON,  AND  C.  F.  SHA~EFER  743 
aplasia when injected into normal animals of the original donor species (16, 17, 
18). Although hypoplastic  marrows were not produced by the dosage of RAMLS 
used in the present experiments,  the results suggested that heterologous anti- 
lymphocyte serum had a similar effect. 
The attempt was made to establish  the mechanism by which RAMLS sup- 
pressed  stem  cell function.  Since the  crude  antiserum possessed  significant 
erythro- and leuko-agglutinating activity it was postulated that such antibodies 
might cause marrow cell agglutination. The resulting cell aggregates could have 
lodged  in the  pulmonary capillaries  of the  irradiated  recipient after intra- 
venous injection and thus be removed from the circulation.  Such a mechanism 
would have decreased the number of spleen colonies formed on a purely me- 
chanical  basis.  This explanation seemed unlikely since stem  cell suppression 
was produced by dilutions of RAMLS which did not cause cell agglutination 
detectable by direct microscopic observation.  Furthermore, the treatment of 
marrow suspensions with RAMLS from which the erythro- and leuko-agglu- 
tinins had been  removed by absorption caused a  decrease  in spleen  colony 
formation equal to that produced by the crude antiserum, indicating that the 
loss of CFU cells could not be correlated with agglutinating activity. 
The cytotoxic action of RAMLS on lymphocyte has been amply demon- 
strated by other investigators (12, 19). The present study has shown that 
RAMLS has a similar cytotoxic effect upon mouse bone marrow cells in vitro. 
Since this was accompanied by a loss of functional CFU cells, these results sug- 
gested that a cytotoxic mechanism might explain the effect of RAMLS upon 
stem cells. As CFU cells cannot be identified morphologically, the direct dem- 
onstration of their injury by RAMLS was not possible. Because of this limi- 
tation, studies were undertaken to determine whether the in vitro cytotoxic 
action of RAMLS on a bone marrow cell population correlated with its sup- 
pression of the CFU cell population. If the effect on the stem ceils  paralled the 
degree of marrow cell destruction, it would be reasonable  to assume  that the 
decrease in CFU cell function was due to a random lysis of all marrow cell types 
by RAMLS. However,  these experiments  established  that marrow ceil popu- 
lations which survived exposure to RAMLS without injury detectable by vital 
staining techniques contained significantly fewer CFU cells than did a compa- 
rable number of normal cells. This suggested that antiserum treatment caused 
an apparent selective loss of stem cells from the marrow preparations. Simi- 
larly, serial  dilution experiments  indicated that profound CFU cell loss fol- 
lowed exposure of bone marrow preparations to antiserum concentrations which 
had no discernible cytotoxic effects on the total marrow population. As stand- 
ard cytotoxicity studies cannot detect minor variations in cell survival (20), 
and since CFU cells account for only 0.2 % of the marrow population, it is possi- 
ble that all the stem cells in the treated preparation could have been selectively 
lysed at high dilutions of RAM-LS  and their destruction would have been missed 
by the assay procedure. 744  ANTI-LYMPHOCYTE  SERUM  AND  HEMOPOIETIC  STEM  CELLS 
This apparent selective destruction of CFU cells could have resulted from 
RAMLS containing high titers of cytotoxic antibody directed against specific 
antigenic determinants of stem cells. This hypothesis would  be particularly 
attractive if the morphological small lymphocytes of mouse bone marrow were 
the mulfipotential hemopoietic stem cells, as has been postulated (21). How- 
ever, it seems unlikely that RAMLS--produced by using lymphocytes as the 
antigenic source--would contain a  tissue-specific antibody which reacted only 
with the lymphoid-like stem cells and did not effect the remaining bone marrow 
lymphocytes. Since the lymphoid cells account for nearly 10 % of the marrow 
population, it seems doubtful that significant destruction of these cells would 
have been overlooked by the test procedures. 
The probable  explanation for the apparent selective action of RAMLS upon 
CFU cells resides in the sensitivity of such cells to injury and not in their spe- 
cific lysis. The cytotoxicity  studies previously described have demonstrated that 
high concentrations of RAM~S can cause  lysis or death of all marrow cell 
types. It seems likely that the same reaction between antibody and marrow 
cells could occur at lower antiserum concentrations.  The resulting cell injury 
may not have produced  lysis or death demonstrable by trypan blue staining, 
but  could  have been  sufficient  to prevent sophisticated biological functions 
such as proliferation  and differentiation (20). If this explanation were correct, 
then the apparent selective loss of CFU cells would result from the different 
methods used to assay injury to stem cells and the general marrow population. 
Previous reports have established that the cytotoxic action of RAMLS upon 
lymphocytes in vitro was complement  dependent (12, 19). In these studies a 
similar complement requirement has been found necessary to produce the cyto- 
toxic action of RAMLS on bone marrow cells. Marrow preparation exposed to 
RAMLS in vitro in the absence of complement formed fewer spleen colonies 
than did control suspensions, indicating that in vitro cytotoxicity  mediated by 
heterologous guinea pig complement was not a prerequisite  for causing  CFU 
cell loss. However,  these findings do not exclude the possibility  that the irra- 
diated host could provide complement in vivo to complete the cytotoxic action 
on antibody-coated cells. Failure to demonstrate an in vitro complement re- 
quirement in this process raised  the possibility that RAMLS prevents stem 
cell function merely by coating these cells. This could interfere  with their re- 
sponse to proliferative  sfimulae in the manner analogous to the "blindfolding" 
hypothesis proposed  by Levey and Medawar (5)  to explain  the immunosup- 
pressive action of the antiserum. Such a mechanism cannot be excluded by the 
present studies, but it fails to account for the demonstrated cytotoxic proper- 
ties of the RAM-LS. 
It could be argued that the marrow changes produced by RAMLS resulted 
from antiserum-stimulated transformation of stem cells into differentiated cell 
lines or nonfunctional blast ceils (1). However,  in its simplest form,  this hy- 
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cursors, and undifferentiated  blast cells from the marrow population, and would 
ignore  the  demonstrated lysis  of  these  cells following in vitro  exposure  to 
RAMLS. Finally, if such stimulation occurred, the injection of antiserum into 
irradiated hosts transfused  with normal marrow should have increased the num- 
ber of spleen colonies formed, while in fact, such treatment decreased splenic 
colonization. 
Regardless of the precise mechanism involved  in RAMLS action, these  in 
vitro studies have established  that the antiserum can produce marrow altera- 
tions mediated by a cytotoxic action directed against diverse marrow cell types. 
It seems plausible that RAMLS has a similar action against stem cells and their 
apparent preferential destruction results  from the ease with which their pro- 
liferative capacity is impaired after injury by the antiserum. 
Since the maintenance of normal marrow function is dependent upon the 
continued replacement  of cellular elements by stem cell proliferation and dif- 
ferentiation, injury to these cells  would alter hemopoiesis. It seems surprising, 
therefore,  that short term  treatment of animals  with conventional doses of 
anti-lymphocyte  serum does not cause pancytopenia. However, the destruction 
of stem cells by small doses of RAMLS could be compensated by increased pro- 
liferation and self-renewal of the unaffected cells resulting in a more rapid turn- 
over of the stem cell pool. The net result of this process would be a diminished 
hemopoietic reserve which would not be reflected by a change in the peripheral 
hemogram.  Higher doses or more prolonged administration of RAMLS could 
conceivably  overwhelm  this compensatory mechanism and result  in  obvious 
clinical abnormalities.  Indeed this could help explain the varied hematological 
finding seen in normal animals chronically treated with anti-lymphocyte serum 
such as the thrombocytopenia described in primates (22) and the unexplained 
anemia noted in dogs (7). Alternatively, animals having decreased marrow re- 
serve because of existing disease or concomitant immunosuppressive  treatment 
might be unable to compensate  for the marrow insult produced by standard 
doses of anti-lymphocyte serum.  There is evidence for this hypothesis in the 
present study, as RAM-LS was found to cause a marked mortality in mice re- 
ceiving prior sublethal irradiation. Further, preliminary histological studies in 
these animals have indicated that hemopoietic tissue regeneration  was severely 
impaired.  If these results could be generalized to humans, such a mechanism 
could help explain the complication of leukopenia  and thrombocytopenia seen 
in patients receiving anti-lymphocyte serum in combination with azathioprine 
after renal transplantation (23). 
The  mechanism  of  the  immunosuppressive  action  of  heterologous  anti- 
lymphocyte serum remains unknown.  The experiments  reported here have il- 
lustrated that minute concentrations of RAMLS can injure hemopoietic stem 
cells and prevent their proliferating to form a  clonal progeny. If this action 
could be generalized to other stem ceils, it would be reasonable to suggest that 
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stimulation might  be equally susceptible to injury by the antiserum.  Such a 
selective interference with these responding lymphocytes would prevent their 
yielding a progeny of committed effector cells, and thus inhibit the immune re- 
sponse without causing  a detectable depletion of the general  lymphoid popula- 
tion as noted by Anderson and associates (24). If the analogy between the effects 
of RAMLS upon hemopoietic stem cells and antigen-induced proliferation  of 
lymphocytes were valid, this stem cell injury could be achieved in vivo at doses 
which cause minimal peripheral cytotoxic effects (Text fig. 1). 
Previous experiments provide precedence for such a hypothesis. Mice treated 
with anti-lymphocyte serum have  exhibited initial  destruction  of  the lymph 
node germinal centers (12) suggesting active lymphocyte proliferation is affected 
by doses of RAMLS that do not apparently affect the remaining lymphoid pop- 
ulation.  Other  investigators have demonstrated  that  the  delay of antiserum 
treatment for 5 or more days after skin grafting resulted in only modest pro- 
longation of graft survival (2, 5).  Such a delay would provide adequate time 
for proliferation of specific effector cells (25),  and even if some of these cells 
were destroyed by the cytotoxic action of RAMLS administered in high doses, 
sufficient numbers could remain to carry out homograft rejection in an atten- 
uated form. 
SUMMARY 
The present study has demonstrated  that rabbit anti-mouse  lymphocyte 
serum (RAMLS)  has the capability  of destroying bone marrow cells  and sup- 
pressing  hemopoictic stem cell  function.  The in  vitro  incubation of  bone  marrow 
suspensions with RAM-LS  caused extensive cell  lysis  with an apparent pref- 
erential  destruction of lymphoid, erythroid,  and blastoid  elements. Using the 
spleen  colony assay,  the number of  functional  hcmopoictic stem cells  was found 
to be markedly  reduced in bone marrow  populations exposed to RAMLS  in 
vitro. Further, this  loss  of stern  cell  function could bc produced by exposing 
marrow  suspensions to small concentrations of antiserum which did not pro- 
duce detectable cytotoxic  effects  on the general  marrow population. 
A  similar  effect  of RAMLS  upon hemopoietic  stem cells  was found in vivo. 
The intravenous  injection  of RAMLS  into  lethally  irradiated  mice immcdi- 
atcly  after  the infusion  of  isogcncic  marrow cells  reduced the number of spleen 
colonies formed,  indicating that the antiserum  could  exhibit a  deleterious 
effect  upon stem cells  in  the bloodstream of  the intact  animal. Normal  animals 
treated with daily subcutaneous injections  of RAMLS  for 3 wk had a signif- 
icantly  reduced marrow content of  functional  hcmopoictic stem cells,  suggesting 
that RAMLS  can affect  stem cells  located  in situ  in the bonc marrow. The ex- 
periments indicate  that RAMLS  possesses  potential  marrow toxicity. 
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EXPLANATION OF PLATE 81 
FIG.  la.  Imprint of normal CsH mouse bone marrow showing numerous erythroid 
and lymphoid elements.  X  400. 
FIG.  lb.  Imprint of C~-I mouse bone marrow after 3 wk of daily treatment  with 
0.25  ml s.c.  of RAMLS showing a  marrow population  composed almost entirely of 
myeloid cells.  X 400. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  127  PLATE  81 
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